BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37732493)

  • 1. Perspectives for immunotherapy of EBV-associated GLELC: A relatively "hot" tumor microenvironment.
    Lei Y; Cao P; Zheng X; Wei J; Cheng M; Liu M
    Cancer Med; 2023 Oct; 12(19):19838-19849. PubMed ID: 37732493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.
    Huang YH; Zhang CZ; Huang QS; Yeong J; Wang F; Yang X; He YF; Zhang XL; Zhang H; Chen SL; Zheng YL; Deng R; Lin CS; Yang MM; Li Y; Jiang C; Kin-Wah Lee T; Ma S; Zeng MS; Yun JP
    J Hepatol; 2021 Apr; 74(4):838-849. PubMed ID: 33212090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr Virus Positive Gastric Cancer: A Distinct Subtype Candidate for Immunotherapy.
    Pereira MA; Batista DAM; Ramos MFKP; Cardili L; Ribeiro RRE; Dias AR; Zilberstein B; Ribeiro U; Cecconello I; Alves VAF; Mello ES
    J Surg Res; 2021 May; 261():130-138. PubMed ID: 33429221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of tumor-infiltrating lymphocytes within the tumor microenvironment in gastric cancer.
    Pereira MA; Ramos MFKP; Cardili L; de Moraes RDR; Dias AR; Szor DJ; Zilberstein B; Alves VAF; de Mello ES; Ribeiro U
    J Gastrointest Surg; 2024 Feb; 28(2):151-157. PubMed ID: 38445936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer.
    Shi J; Yang X; Wang X; Luo Y; Zhou W; Luo H; Bianba Z; Nima Z; Wang Q; Wang H; Liao R; Ciren Q; Li M; Pang J
    Biomed Res Int; 2022; 2022():2684065. PubMed ID: 35734348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor prognosis in Epstein-Barr virus-negative gastric cancer with lymphoid stroma is associated with immune phenotype.
    Cho CJ; Kang HJ; Ryu YM; Park YS; Jeong HJ; Park YM; Lim H; Lee JH; Song HJ; Jung HY; Kim SY; Myung SJ
    Gastric Cancer; 2018 Nov; 21(6):925-935. PubMed ID: 29627937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma.
    Chiang NJ; Hou YC; Tan KT; Tsai HW; Lin YJ; Yeh YC; Chen LT; Hou YF; Chen MH; Shan YS
    Hepatol Int; 2022 Oct; 16(5):1137-1149. PubMed ID: 35780451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.
    Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC
    Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes.
    Kang HJ; Oh JH; Chun SM; Kim D; Ryu YM; Hwang HS; Kim SY; An J; Cho EJ; Lee H; Shim JH; Sung CO; Yu E
    J Hepatol; 2019 Jul; 71(1):91-103. PubMed ID: 30930222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8
    Abe H; Saito R; Ichimura T; Iwasaki A; Yamazawa S; Shinozaki-Ushiku A; Morikawa T; Ushiku T; Yamashita H; Seto Y; Fukayama M
    Virchows Arch; 2018 Apr; 472(4):643-651. PubMed ID: 29536167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression.
    Gullo I; Oliveira P; Athelogou M; Gonçalves G; Pinto ML; Carvalho J; Valente A; Pinheiro H; Andrade S; Almeida GM; Huss R; Das K; Tan P; Machado JC; Oliveira C; Carneiro F
    Gastric Cancer; 2019 Jan; 22(1):77-90. PubMed ID: 29779068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein-Barr Virus-Associated Malignancies.
    Zheng X; Huang Y; Li K; Luo R; Cai M; Yun J
    Viruses; 2022 May; 14(5):. PubMed ID: 35632758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection.
    Barros MH; Vera-Lozada G; Soares FA; Niedobitek G; Hassan R
    Int J Cancer; 2012 Sep; 131(5):1142-52. PubMed ID: 22025264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype.
    Kim TS; da Silva E; Coit DG; Tang LH
    Am J Surg Pathol; 2019 Jun; 43(6):851-860. PubMed ID: 30969179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation in gastric adenocarcinoma of the cardia: how do EBV infection, Her2 amplification and cancer progression influence tumor-infiltrating lymphocytes?
    Haas M; Büttner M; Rau TT; Fietkau R; Grabenbauer GG; Distel LV
    Virchows Arch; 2011 Apr; 458(4):403-11. PubMed ID: 21359545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms.
    Nakano H; Saito M; Nakajima S; Saito K; Nakayama Y; Kase K; Yamada L; Kanke Y; Hanayama H; Onozawa H; Okayama H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Goto A; Kono K
    Sci Rep; 2021 Jan; 11(1):1982. PubMed ID: 33479394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer.
    Kang BW; Seo AN; Yoon S; Bae HI; Jeon SW; Kwon OK; Chung HY; Yu W; Kang H; Kim JG
    Ann Oncol; 2016 Mar; 27(3):494-501. PubMed ID: 26673353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability.
    Ma C; Patel K; Singhi AD; Ren B; Zhu B; Shaikh F; Sun W
    Am J Surg Pathol; 2016 Nov; 40(11):1496-1506. PubMed ID: 27465786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance of immune checkpoints within tumor immune contexture and their prognostic significance in gastric cancer.
    Dai C; Geng R; Wang C; Wong A; Qing M; Hu J; Sun Y; Lo AW; Li J
    Mol Oncol; 2016 Dec; 10(10):1551-1558. PubMed ID: 27720576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma.
    Min BH; Tae CH; Ahn SM; Kang SY; Woo SY; Kim S; Kim KM
    Gastric Cancer; 2016 Jul; 19(3):852-9. PubMed ID: 26265391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.